SRF rose 0.79% to Rs 1,456.40 at 9:45 IST on BSE after consolidated net profit rose 22.39% to Rs 113.21 crore on 3.5% increase in total income to Rs 1226.68 crore in Q1 June 2015 over Q1 June 2014.
The result was announced after market hours yesterday, 6 August 2015.
Meanwhile, the S&P BSE Sensex was down 21.56 points or 0.08% at 28,276.57.
On BSE, so far 19,722 shares were traded in the counter as against average daily volume of 27,858 shares in the past one quarter.
The stock hit a high of Rs 1,486 and a low of Rs 1,444.30 so far during the day. The stock had hit a record high of Rs 1,495.55 on 5 August 2015. The stock had hit a 52-week low of Rs 598 on 8 August 2014.
The stock had outperformed the market over the past one month till 6 August 2015, rising 9.28% compared with Sensex's 0.32% gain. The scrip had also outperformed the market in past one quarter, gaining 51.58% as against Sensex's 5.92% gain.
The mid-cap company has equity capital of Rs 57.42 crore. Face value per share is Rs 10.
SRF said increase in Q1 net profit was driven by stabilised performance of the recently commissioned overseas units and an overall improvement in operational efficiencies across all businesses,
SRF said that the board of directors of the company at its meeting held yesterday, 6 August 2015, have approved the payment of an interim dividend of Rs 5 per share for the year ending 31 March 2016 (FY 2016).
SRF said that the board of directors of the company at its meeting held yesterday, 6 August 2015, has approved setting up of a new greenfield packaging film line in the domestic tariff area, Indore at an estimated cost of Rs 356 crore. The board has also approved setting up of R-134a Pharma Grade Manufacturing and Filling facility as per cGMP requirement at Dahej, Gujarat at an estimated cost of Rs 26 crore. The board has further approved converting the HFC 134a plant at Bhiwadi into a swing plant to produce both HFC 134a and HFC 32 at an estimated cost of Rs 12 crore to produce both HFC 134a and HFC 32.
SRF, is a multi business entity engaged in the manufacture of chemical based industrial intermediates.
Powered by Capital Market - Live News
